טוען...
Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods
INTRODUCTION: The identification of metabolomic biomarkers predictive of cancer patient response to therapy and of disease stage has been pursued as a “holy grail” of modern oncology, relying on the metabolic dysfunction that characterizes cancer progression. In spite of the evaluation of many candi...
שמור ב:
| הוצא לאור ב: | Metabolomics |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138701/ https://ncbi.nlm.nih.gov/pubmed/33772663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-021-01787-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|